Uli Hacksell
CIK 1291962 · President and CEO · last filed 2020-04-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.36M
Companies
6
Total Filings
45
Lifetime Open-Market Net
-$10.99M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Avalo Therapeutics, Inc. (CERC) Delisted | Director | 20,000 | $2.93 | $58.6K | $14.9K | 7 | 2020-04-02 |
| Avalo Therapeutics, Inc. (CERCW) Delisted | Director | — | — | — | $0 | 1 | 2018-05-17 |
| Avalo Therapeutics, Inc. (CERCZ) Delisted | President and CEO | — | — | — | $0 | 1 | 2017-01-30 |
| Avalo Therapeutics, Inc. (CERC.Z) Delisted | President and CEO | — | — | — | $0 | 2 | 2016-08-19 |
| Avalo Therapeutics, Inc. (CERC.U) Delisted | Director | — | — | — | $0 | 1 | 2015-11-12 |
| ACAD | CEO | 175,549 | $24.84 | $4.36M | -$11.01M | 32 | 2015-02-19 |
Recent Filings · Page 2 of 5
45 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-08-19 | Avalo Therapeutics, Inc. (CERC.Z) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-01-12 | Avalo Therapeutics, Inc. (CERC.Z) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-11-12 | Avalo Therapeutics, Inc. (CERC.U) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-02-19 | ACAD | Mixed | — | -$982.4K | EDGAR |
| 2015-01-16 | ACAD | Mixed | — | -$959.4K | EDGAR |
| 2014-12-17 | ACAD | Mixed | — | -$869.9K | EDGAR |
| 2014-11-26 | ACAD | Mixed | — | -$818.4K | EDGAR |
| 2014-10-10 | ACAD | Mixed | — | -$664.5K | EDGAR |
| 2014-09-12 | ACAD | Mixed | — | -$760.8K | EDGAR |
| 2014-08-15 | ACAD | Mixed | — | -$240.5K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.